Nuclear Fragile X Mental Retardation Protein Interacting Protein 2 (NUFIP2) Peptide
NUFIP2
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all NUFIP2 products
- NUFIP2 (Nuclear Fragile X Mental Retardation Protein Interacting Protein 2 (NUFIP2))
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-NUFIP2 antibody (Catalog #: ARP51676_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- NUFIP2 (Nuclear Fragile X Mental Retardation Protein Interacting Protein 2 (NUFIP2))
- 别名
- 182-FIP Peptide, 82-FIP Peptide, FIP-82 Peptide, 182-fip Peptide, 82-fip Peptide, fip-82 Peptide, pig1 Peptide, 1110001M19Rik Peptide, 9530056D24Rik Peptide, AI256692 Peptide, AI461731 Peptide, PIG1 Peptide, mKIAA1321 Peptide, NUFIP2, FMR1 interacting protein 2 Peptide, nuclear fragile X mental retardation protein interacting protein 2 L homeolog Peptide, nuclear fragile X mental retardation protein interacting protein 2 Peptide, NUFIP2 Peptide, nufip2.L Peptide, Nufip2 Peptide
- 背景
-
NUFIP2 binds RNA. It is phosphorylated upon DNA damage, probably by ATM or ATR. The exact functions of NUFIP2 remain unknown.
Alias Symbols: 182-FIP, 82-FIP, FIP-82, FLJ10976, KIAA1321, MGC117262, PIG1
Protein Interaction Partner: FMR1,YWHAG,FMR1,G3BP1,G3BP2
Protein Size: 695 - 分子量
- 76 kDa
- 基因ID
- 57532
- NCBI登录号
- NM_020772, NP_065823
- UniProt
- Q7Z417
-
You are here:
